208 results on '"Chapman, Joab"'
Search Results
2. The epidemiological and clinical characteristics of patients with young-onset genetic Creutzfeldt-Jakob disease
3. Serum Neurofilament Light Chain Levels in Small Fiber Neuropathy Patients with Skin Denervation and Ongoing Neuropathic Symptoms (P14-8.004)
4. Neurological Disorders
5. List of Contributors
6. Exercise Induced Muscle Blood Flow is Decreased in CMT1 Polyneuropathy: A Power Doppler Analysis
7. Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
8. PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy
9. LPS-Induced Coagulation and Neuronal Damage in a Mice Model Is Attenuated by Enoxaparin
10. Genetic Creutzfeldt‐Jakob disease in Turkish Jews—demographic and clinical features
11. Thrombin Activity in Rodent and Human Skin: Modified by Inflammation and Correlates with Innervation
12. Factor VII, EPCR, aPC Modulators: novel treatment for neuroinflammation
13. LPS Induced Coagulation and Neuronal Damage in a Mice Model is Attenuated by Enoxaparin
14. Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model teriflunomide in anti-ANXA2 mice model
15. Five Years Analysis of anti-Glatiramer Acetate (GA) Antibodies in Patients with Relapsing Remitting Multiple Sclerosis Treated with GA Depot (P5-4.010)
16. Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease
17. Intrinsic Expression of Coagulation Factors and Protease Activated Receptor 1 (PAR1) in Photoreceptors and Inner Retinal Layers
18. Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems
19. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis
20. Narcolepsy, Infections, and Autoimmunity
21. Infections as a Cause of Guillain–Barré Syndrome
22. Contributors
23. Spatial distribution of abnormal EEG activity in Creutzfeldt-Jakob disease
24. Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
25. Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model
26. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome
27. Markers for neural degeneration and regeneration: novel highly sensitive methods for the measurement of thrombin and activated protein C in human cerebrospinal fluid
28. Increased brain plasmin levels following experimental ischemic stroke in male mice
29. Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule
30. In-thrombus thrombin secretion: a new diagnostic marker of atrial fibrillation in cryptogenic stroke
31. Task Force Report on Brain Involvement in Antiphospholipid Syndrome
32. Neuromylelitis Optica (Devic Syndrome)
33. Autoimmune Chorea
34. Guillain-Barré and Other Immune-Mediated Neuropathies
35. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome
36. Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis
37. Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course
38. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy
39. Glatiramer Acetate Depot (extended-release) phase IIa study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (No Evidence of Disease Activity) subpopulation three-years analysis (1936)
40. A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF
41. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology
42. Vasculitides—Miscellaneous Vasculitides
43. Rheumatoid Arthritis: Peripheral and Central Nervous System Involvement
44. The association of quantitative EEG and MRI in Creutzfeldt‐Jakob Disease
45. The role of thrombin in the pathogenesis of diabetic neuropathy
46. Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Relapsing Remitting Multiple Sclerosis: Safety, Tolerability and Efficacy (No Evidence of Disease Activity) Two-Years Analysis (P3.2-052)
47. The impact of self-replicating proteins on inflammation, autoimmunity and neurodegeneration—An untraveled path
48. The Effect of Neuronal Activity on Glial Thrombin Generation
49. Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis
50. A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.